Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
about
Monitoring of the Immune Dysfunction in Cancer PatientsStandard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer.Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines.
P2860
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
@ast
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
@en
type
label
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
@ast
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
@en
prefLabel
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
@ast
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
@en
P2093
P2860
P1476
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
@en
P2093
Jaap Oostendorp
Kees L M C Franken
Marij J P Welters
Mehrdad Talebian Yazdi
Nikki M Loof
Pieter S Hiemstra
Sjoerd H van der Burg
P2860
P2888
P304
P356
10.1007/S00262-015-1716-2
P577
2015-05-30T00:00:00Z
P5875
P6179
1020613995